ArticleEndocrinology2025
Growing Pains: GH-induced Fibrosis Across Multiple Organs in bGH Mice.
Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cumulative effects of lifelong systemic excess growth hormone on postcranial skeletal morphology in adult mice.Journal of anatomy · 2026Article
- Growth Hormone, Not Simply Just a Hormone for Growth.Endocrinology and metabolism (Seoul, Korea) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Fibrosis, excessive extracellular matrix deposition, disrupts normal tissue function. It has been observed in select tissues of individuals with acromegaly and in transgenic mouse models of acromegaly, suggesting a role of GH and/or IGF-1. However, analysis across multiple tissues and ages has not been reported. This study evaluated fibrosis in 6 tissues -lung, kidney, liver, spleen, quadriceps, and heart-from young (3 months) and aged (12-15 months) bovine GH transgenic and wild-type mice of both sexes. Fibrosis was assessed using hydroxyproline content, picrosirius red (PSR) staining, and serum biomarkers of collagen turnover (PINP, ICTP, and FAP). Hydroxyproline assays showed collagen content significantly increased with age across all tissues and both sexes. Compared to wild-type, aged male bGH mice had elevated hydroxyproline in the lung, kidney, liver, and quadriceps; aged female bGH mice showed increases in kidney, liver, and quadriceps. PSR staining showed minimal differences in young mice. In aged bGH mice, males exhibited increased PSR staining in all tissues except lung; females showed increases in all tissues except lung and heart. Serum biomarkers showed sex- and age-specific patterns: PINP decreased with age in both sexes; ICTP increased with age in both sexes; FAP was lower in bGH mice and decreased with age in females. In conclusion, excess GH promotes fibrosis in most tissues studied and becomes more pronounced with advancing age, suggesting fibrosis is a common outcome of excess GH. Whether fibrosis is directly caused by GH/IGF-1 or secondary to poor health of bGH mice requires further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.